Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/2012
03/28/2012CN102389544A Traditional Chinese medicine for treating diabetic foot
03/28/2012CN102389513A Processing method of polyphylla medicinal material
03/28/2012CN102389503A Traditional Chinese medicine for curing diabetic peripheral neuropathy
03/28/2012CN102389502A Chinese medicine for treating diabetic peripheral neuropathy
03/28/2012CN102389501A Chinese medicine for treating diabetic peripheral neuropathy
03/28/2012CN102389486A Traditional Chinese medicine for treating cancerous pain
03/28/2012CN102389450A Xihong tongluo oral solution capable of fast passing through blood-brain barrier
03/28/2012CN102389446A Ginseng steaming method
03/28/2012CN102389438A Application of Astragaloside IV
03/28/2012CN102389437A Application of Centella triterpenes in preparing products for improving cerebral apoplexy sequelae
03/28/2012CN102389435A Application of pseudojujubogenin to preparation of medicaments for resisting senile dementia
03/28/2012CN102389430A Application of small molecular compounds to preparation of anti-lung-cancer medicine
03/28/2012CN102389428A Application of ligustrazine in preparing medicament for treating or preventing chronic anoxic bulbar injury
03/28/2012CN102389423A Medicinal composition containing ibuprofen sodium salt
03/28/2012CN102389406A Application of resveratrol in preparation of medicines for treating P2X3-mediated chronic pain diseases
03/28/2012CN102389383A Perfume having anti-depression and refreshing functions and manufacturing method thereof
03/28/2012CN102389382A Perfume having antianxiety and refreshing functions and manufacturing method thereof
03/28/2012CN102389245A Formula of health care medicine pillow for detoxifying and health-promoting
03/28/2012CN102389234A Myrica rubra kernel health care mattress
03/28/2012CN102139086B Traditional Chinese medicine for treating liver stagnation and spleen deficiency type post-stroke depression
03/28/2012CN102106998B Chinese medicine for treating insomnia
03/28/2012CN102106918B Method for simultaneously preparing volatile oil, total flavones and total alkaloids from immature bitter oranges
03/28/2012CN102028757B Processing method of mulberry composite extract
03/28/2012CN102018736B Natural indigo decoction piece and preparation method thereof
03/28/2012CN101982138B Medicine pillow for refreshing mind and dispelling stagnation
03/28/2012CN101961325B Application of emodin in preparation of drugs for treating depression
03/28/2012CN101926938B Drug for curing tinnituscerebri
03/28/2012CN101912386B Application of quercetin dimer flavone for preparing anti-oxidation medicines
03/28/2012CN101812065B Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
03/28/2012CN101781226B Agomelatine and medicine composition thereof
03/28/2012CN101759665B Substituent phenylpiperazine aryl alkanol derivant and application thereof in preparing analgesics
03/28/2012CN101698095B Drug composition liniment or lotion for treating white vein diseases and preparation method thereof
03/28/2012CN101632724B Application of polygonum orientale and erigeron breviscapus composition in preparing medicaments for treating cerebrovascular disease and correlative diseases
03/28/2012CN101550132B Arylvinylazacycloalkane compounds and methods of preparation and use thereof
03/28/2012CN101518581B Compound gardenia oil soft capsule and method for preparing same
03/28/2012CN101397270B Polymorphic substance of donepezil salt, preparation and use thereof
03/28/2012CN101395142B 4-amino-1,5-substituted 1,5-dihydro-imidazol-2-ones
03/28/2012CN101366832B Method for preparing compound cavel capsule
03/28/2012CN101332235B Magnolia bark and processing technique
03/28/2012CN101084178B (benzyloxy-biphenyl) acetic acids and derivatives thereof
03/27/2012USRE43280 Hyperforin derivatives, the use thereof and formulations containing them
03/27/2012US8143424 Thyroid like compounds
03/27/2012US8143317 Use of xenon for treating neurointoxications
03/27/2012US8143297 Heterocyclic derivatives as modulators of ion channels
03/27/2012US8143282 Heterocyclic compounds
03/27/2012US8143267 Dosing interval of the nimesulide overlaps with that of the oxycodone to reduce the amount of oxycodone needed to provide an effect
03/27/2012US8143220 Dosing regimens for neural stem cell proliferating agents and differentiating agents for the treatment of neurological disorders
03/27/2012US8143005 Nucleic acids encoding sodium channel SCN1A alpha subunit proteins and mutations associated with epilepsy
03/27/2012US8142811 Controlled release hydrocodone formulations
03/27/2012US8142778 Methods of treatment using CTLA-4 antibodies
03/27/2012CA2682329C Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists
03/27/2012CA2676456C Tosylate salt of a therapeutic compound and pharmaceutical compositions thereof
03/27/2012CA2524898C 6-arylmethyl-substituted pyrazolopyrimidines
03/27/2012CA2513427C Compounds having anti-proliferative properties
03/27/2012CA2470245C Ifnar2 mutants, their production and use
03/27/2012CA2454699C Method for treating primary insomnia
03/27/2012CA2447091C Methods for the treatment and prevention of pain using stress-activated protein kinase
03/27/2012CA2389570C Methods for treating mild cognitive impairment
03/27/2012CA2309903C Nucleic acid sequences encoding capsaicin receptor
03/22/2012WO2012037397A2 Step-derived peptide for brain injury treatment
03/22/2012WO2012037239A1 Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia
03/22/2012WO2012037093A1 Compositions for treating cancer treatment - related fatigue
03/22/2012WO2012036506A2 Composition for promoting memory and learning ability
03/22/2012WO2012036433A2 Treatment of neurodegenerative diseases by targeting mirna
03/22/2012WO2012036278A1 Glycine transporter inhibitor
03/22/2012WO2012036276A1 Glycine transporter inhibitory substance
03/22/2012WO2012036268A1 Glycine transporter inhibitory substance
03/22/2012WO2012036233A1 Condensed heterocyclic derivative having melanine-concentrating hormone receptor antagonistic activity
03/22/2012WO2012036191A1 Composition for improving brain function and method for improving brain function
03/22/2012WO2012035871A1 Brain function enhancement composition and method for enhancing brain function
03/22/2012WO2012035409A1 Sustained release compositions of anti-alzheimer's agents
03/22/2012WO2012035216A1 Dihydrobenzoxathiazepine derivatives, preparation thereof, pharmaceutical compositions and use as ampa receptor modulators
03/22/2012WO2012035123A1 Arylosulfonamides for the treatment of cns diseases
03/22/2012WO2012035113A1 Type-1 interferons for treatment of multiple sclerosis
03/22/2012WO2012034232A1 Terpenoid analogues and uses thereof for treating neurological conditions
03/22/2012WO2012034189A1 Methods of using mirnas transcribed from the 14q32 region of human chromosome 14 as biomarkers for schizophrenia or symptoms thereof
03/22/2012WO2012016314A9 Arachidonic acid-derived coxib analogue-substituted compounds for use in treating pain
03/22/2012WO2012013850A3 Compound for treating neurodegenerative diseases, cognitive deficiencies and/or dementia
03/22/2012WO2012007658A3 Use of the pat nonapeptide in treating and preventing neurodegenerative diseases
03/22/2012WO2012001308A9 Method for synthesizing ergoline alkaloids from indolic bicyclic compounds by double cyclization, resulting materials, and intermediate materials
03/22/2012WO2004050019A9 Method and compositions for treating anxiety
03/22/2012US20120071657 Triazole compounds useful as protein kinase inhibitors
03/22/2012US20120071561 Methods And Compositions For Prevention And Treatment Of Inflammatory Disease, Autoimmune Disease And Transplant Rejection
03/22/2012US20120071560 Monoamine reuptake inhibitors
03/22/2012US20120071558 Compositions of very long chain polyunsaturated fatty acids and methods of use
03/22/2012US20120071556 Pharmaceutical and nutraceutical compositions of abscisic acid
03/22/2012US20120071554 Deuterated 2-propylpentanoic acid compounds
03/22/2012US20120071550 Synergistic combinations of cartonoids and polyphenols
03/22/2012US20120071548 Therapeutic compositions
03/22/2012US20120071547 Compounds from soft coral, method of preparation and pharmaceutical uses thereof
03/22/2012US20120071546 Novel Glutamic Acid Decarboxylase (GAD) Chimera And Methods Of Use
03/22/2012US20120071539 Compounds and methods for modulating the silencing of a polynucleotide of interest
03/22/2012US20120071536 N-[(2-azabicyclo[2.1.1]hex-1-yl)-aryl-methyl]-benzamide derivatives, preparation thereof, and therapeutic use thereof
03/22/2012US20120071535 Estrogen receptor modulators and uses thereof
03/22/2012US20120071534 Lxr modulators
03/22/2012US20120071529 Tetrazole Compounds Which Selectively Modulate The CB2 Receptor
03/22/2012US20120071514 Benzoxazolone derivatives as aldosterone synthase inhibitors
03/22/2012US20120071512 5-pyridin-3-yl-1, 3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or cyp11b1
03/22/2012US20120071511 Fentanyl-containing adhesive preparation for external use
03/22/2012US20120071510 Method and Composition for Treating Migraines
1 ... 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 ... 1833